TCL readership survey

Thank you for agreeing to participate in this research. Your data will help us to improve The Cancer Letter. For information about how we process data, please visit our Terms of Service and our Privacy Policy.

This survey should take about 10 minutes to complete.

Street Address

Street Address Line 2

Country

Street Address

Street Address Line 2

CityState

Street Address

Street Address Line 2

CityState

I pay for my own subscriptionMy employer pays for my subscriptionNot a subscriberOther

	N/A	Disagree	Somewhat agree	Agree
The Cancer Letter is worth the price.
The Cancer Letter offers in-depth coverage of topics that matter to me.
My colleagues often discuss articles in The Cancer Letter.
The Cancer Letter's reporting is accurate and thoughtful.
I appreciate the lower volume of ads in The Cancer Letter, compared to other publications.
I trust The Cancer Letter to provide unbiased coverage.
The Cancer Letter is my primary source of oncology news.
The ads in The Cancer Letter are relevant to me.

Weekly/every issueEvery other week (semi-weekly)Once a monthLess than once a month

The following questions are about The Cancer Letter PDF edition, which is available for download on CancerLetter.com or may be distributed to you in other ways.

I download it from CancerLetter.comI download it from my employer's intranetThe PDF is emailed to me directlyMy employer provides a printed copyI direct someone to download and/or print it for meOther

	N/A	Not Satisfied	Somewhat Satisfied	Satisfied
Ease of download
Readability
Navigation
Design
Number of advertisements

The following questions are about The Cancer Letter website, CancerLetter.com.

Logged in automatically (IP Login)Username/passwordI do not have an accountOther

	N/A	Not Satisfied	Somewhat Satisfied	Satisfied
Login process
Readability
Navigation
Accessibility settings (for example: keyboard navigation, font size, color contrast, ...)
Mobile site
Number of advertisements

1 is Not at all satisfied, 10 is Extremely satisfied

	Not interested	Somewhat interested	Interested	Very interested
Healthcare policy
Health disparities
Cancer center news
FDA
Paylines
Drug approvals
Community oncology
Global oncology
Workplace equity in academic medicine
Interviews with cancer center directors
Reimbursement news
NCI
Long form Q&A-style interviews
Artificial Intelligence (AI)
Real-world evidence (RWE)
Cancer history

NoOpen to opportunities but not actively lookingYes, actively lookingNo, plan to start looking within the next 6 monthsNo, plan to start looking within the next year

Readership Survey